Radiopharmaceutical provider P.E.T.Net Pharmaceuticals of Knoxville, TN has signed a licensing agreement with the University of California, Los Angeles, for development rights to molecular imaging probes for the COX-2 enzyme.
P.E.T.Net, a subsidiary of Knoxville, TN-based CTI Molecular Imaging, and UCLA collaborated in establishing the L.A. Tech Center in 2001 to study molecular therapeutics. COX-2 is an enzyme that causes inflammatory disorders, and UCLA is researching the enzyme.By AuntMinnie.com staff writers
November 4, 2002
Copyright © 2002 AuntMinnie.com